Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. [electronic resource]
Producer: 20150213Description: 77-84 p. digitalISSN:- 1879-0712
- AMP-Activated Protein Kinases -- metabolism
- Animals
- Hemodynamics -- drug effects
- Interleukin-6 -- blood
- Isoproterenol -- adverse effects
- Male
- Metformin -- pharmacology
- Myeloid Differentiation Factor 88 -- metabolism
- Myocardial Infarction -- chemically induced
- Myocardium -- metabolism
- Phosphorylation -- drug effects
- RNA, Messenger -- genetics
- Rats
- Rats, Wistar
- Signal Transduction -- drug effects
- Time Factors
- Toll-Like Receptor 4 -- genetics
- Tumor Necrosis Factor-alpha -- blood
- Ventricular Dysfunction, Left -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.